EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Viable Cryopreservation Strategy for Extending the Timeframe of Circulating Tumor Cell Detection in Breast Cancer Clinical Trials

Cristina Sánchez-Quesada iD, Estefanía Toledo iD, José Juan Jiménez-Moleón iD, José Juan Gaforio iD

Biomolecules · 2025

DOI: 10.3390/biom15050723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Cristina Sánchez-Quesada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, Faculty of Health Sciences, University of Jaén, 23071 Jaén, Spain. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Cryopreservation, Breast Neoplasms. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) hold recognized prognostic value in various cancers, including breast cancer, where their presence correlates with survival outcomes. However, the typical 24 h window for blood processing and CTC isolation poses a logistical challenge, particularly for multicenter studies. This study aimed to evaluate cryopreservation at different stages of CTC isolation and immunocytological detection to extend the blood sample processing period. Using spiked peripheral blood samples with MDA-MB-231, SKBR3, and MCF7 breast cancer cell lines, four distinct cryopreservation points were assessed: following Ficoll gradient separation, immunomagnetic separation, cytocentrifugation, and cytokeratin labeling. Our findings demonstrated that cryopreservation of the mononuclear and granulocytic cell fraction after double-density Ficoll gradient separation was the only viable method for subsequent CTC detection. This approach allowed for consistent recovery of CK+ CTCs, with an average recovery rate of over 81% after one year of cryopreservation. In contrast, cryopreservation at later stages resulted in undetectable CTCs or only cellular debris. In conclusion, cryopreservation following density gradient centrifugation is a feasible strategy for delaying CTC isolation and immunocytological analysis in breast cancer research, facilitating its application in multicenter clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingCryopreservationBreast NeoplasmsHumansFemaleCell Line, TumorMCF-7 CellsCell SeparationClinical Trials as Topic

Stichwörter der Autor:innen

fluid biopsyimmunodetectionliquid biopsytumor cell

Autor:innen und Institutionen

  • Department of Health Sciences, Faculty of Health Sciences, University of Jaén, 23071 Jaén, Spain.
  • University Institute of Research on Olive and Olive Oils (INUO), University of Jaen, Campus las Lagunillas s/n, 23071 Jaén, Spain.
  • Agrifood Campus of International Excellence (ceiA3), 14071 Córdoba, Spain.
  • Department of Preventive Medicine and Public Health, University of Navarra, C/Irunlarrea, 1, 31008 Pamplona, Spain.
  • IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
  • CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.

ORCID-Profile: Cristina Sánchez-Quesada, Estefanía Toledo, José Juan Jiménez-Moleón, José Juan Gaforio

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Sánchez-Quesada, C., Toledo, E., Jiménez-Moleón, J. J., & Gaforio, J. J. (2025). Viable Cryopreservation Strategy for Extending the Timeframe of Circulating Tumor Cell Detection in Breast Cancer Clinical Trials. Biomolecules. https://doi.org/10.3390/biom15050723

Vancouver

Sánchez-Quesada C, Toledo E, Jiménez-Moleón JJ, Gaforio JJ. Viable Cryopreservation Strategy for Extending the Timeframe of Circulating Tumor Cell Detection in Breast Cancer Clinical Trials. Biomolecules. 2025. doi:10.3390/biom15050723

BibTeX
@article{SnchezQuesada2025,
  author = {Sánchez-Quesada, Cristina and Toledo, Estefanía and Jiménez-Moleón, José Juan and Gaforio, José Juan},
  title = {Viable Cryopreservation Strategy for Extending the Timeframe of Circulating Tumor Cell Detection in Breast Cancer Clinical Trials},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15050723}
}
Kostenlos starten →